| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/26/2003 | EP1284734A1 Protein kinase inhibitors |
| 02/26/2003 | EP1284730A1 Aralkyl ester soft drugs |
| 02/26/2003 | EP1284728A1 Pharmaceuticals for treating obesity |
| 02/26/2003 | EP1284721A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 02/26/2003 | EP1284718A2 Occlusive transdermal therapeutic system wit a non-occlusive backing layer |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 02/26/2003 | EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/26/2003 | EP0971901B1 Phthalazinones |
| 02/26/2003 | EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 02/26/2003 | EP0822986B1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/26/2003 | EP0770137B1 Improvements in production of proteins in host cells |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | EP0754040B1 Rapamycin derivatives |
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/26/2003 | CN1399559A Micro-cluster liquids and methods of making and using them |
| 02/26/2003 | CN1399550A Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 02/26/2003 | CN1399543A Controlled release composition comprising nimesulide |
| 02/26/2003 | CN1398869A Process of extracting tannic acid from Geranium wilfordii root and the use of the extractive |
| 02/26/2003 | CN1398626A Yinhuang powder injection for intravenous injection and its prepn process |
| 02/26/2003 | CN1398618A Chinese medicine capsule for treating rbeumatism and protrusion of lumber interverterbral disc |
| 02/26/2003 | CN1398613A Lumbago treating Chinese herbal medicine |
| 02/26/2003 | CN1398599A Rheumatism treating nux vomica medicine powder |
| 02/26/2003 | CN1102062C Enqlish yew-sufflower tea |
| 02/26/2003 | CN1102054C Medical wine for treating rheumatoid arthritis |
| 02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | CA2419744A1 A novel crystal of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-¬n-(4-phenoxyphenylcarbonyl)amino|pentanamide and a method for the preparation thereof and a pharmaceutical agent comprising the same as active ingredient |
| 02/25/2003 | US6525214 Contacting 2-(4-isobutylphenyl)propionic acid of high enantiomorph purity with sodium base; salt formation to form sodium ibuprofen; analgesics, antipyretics, antiinflammatory agents |
| 02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 02/25/2003 | US6525184 Self-regulated apoptosis of inflammatory cells |
| 02/25/2003 | US6525102 Increasing storage stability of interleukin-2 by incorporating free base form arginine and succinic acid |
| 02/25/2003 | US6525098 Treatment of inflammation, rheumatic, arthritic conditions; improved hydrolysis and solubility; reduced propensity to cause stomach irritation; analgesics and antipyretics |
| 02/25/2003 | US6525083 Antidiabetic agents, antilipemic agents, anticholesterol agents |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525067 Substituted heterocyclic derivatives |
| 02/25/2003 | US6525062 Method of treating pain using nalbuphine and opioid antagonists |
| 02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
| 02/25/2003 | US6525055 Allergic and inflammatory pathologies such as, for example, emphysema, chronic bronchitis, asthma and allergic rhinitis. |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/25/2003 | US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524623 Therapeutic compositions and methods of use thereof |
| 02/25/2003 | US6524593 N-acetyl aldosamines and related N-acetyl compounds, and their topical use |
| 02/25/2003 | US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | WO2002016328A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | WO2002016323A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2420208A1 Biphenyl derivatives and their use as integrin inhibitors |
| 02/21/2003 | CA2420205A1 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/20/2003 | WO2003014745A2 Method for identifying anti-inflammatory drugs |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014309A2 Interleukin-1 receptors in the treatment of diseases |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014124A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 02/20/2003 | WO2003014112A1 Crystal and process for producing the same |
| 02/20/2003 | WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors |
| 02/20/2003 | WO2003014101A1 Hydroxamic acid derivatives |
| 02/20/2003 | WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014091A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/20/2003 | WO2003014089A1 Aminotetrahydroisoquinoline derivatives as analgesics |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2003013606A1 Thrombomodulin-containing medicinal compositions |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013577A2 Use of il-18 inhibitors in hypersensitivity disorders |
| 02/20/2003 | WO2003013574A1 Melanin-concentrating hormone antagonists |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | WO2003013531A1 Phenyl derivatives as factor xa inhibitors |
| 02/20/2003 | WO2003013530A2 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2003013509A1 N-phenylpyrrole guanidine derivatives as melanocortin reception ligands |
| 02/20/2003 | WO2003013493A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 02/20/2003 | WO2003013475A1 Injectable foam and novel pharmaceutical applications thereof |
| 02/20/2003 | WO2003013473A1 Stabilized oral suspension formulation |
| 02/20/2003 | WO2003013458A1 Cosmetic and/or pharmaceutical preparations containing plant extracts |
| 02/20/2003 | WO2003013436A2 Kavalactone compositions and methods of use |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013433A2 Sequestered antagonist formulations |
| 02/20/2003 | WO2003013432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 02/20/2003 | WO2003013428A2 Nutritional supplements and methods of using same |
| 02/20/2003 | WO2002102794A3 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 02/20/2003 | WO2002098427A3 Sustained-release analgesic compounds |
| 02/20/2003 | WO2002096927A3 Ribozyme based treatment of female reproductive diseases |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002096422A3 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways |